MGTA - Magenta Therapeutics EPS beats by $0.08 November, 05 2020 08:21 AM Magenta Therapeutics Inc. Magenta Therapeutics (MGTA): Q3 GAAP EPS of -$0.37 beats by $0.08.Cash, cash equivalents and marketable securities of $161.7MPress Release For further details see: Magenta Therapeutics EPS beats by $0.08